(CNK) Cinemark Holdings - NYSE
Sector: Communication Services | Industry: Entertainment | Exchange: NYSE (USA) | Market Cap: 3.856m USD | Total Return: 4.7% in 12m
Avg Turnover: 67.9M
Qual. Beats: 0
Rev. Trend: 68.5%
Qual. Beats: 0
Warnings
Altman Z'' 0.10 < 1.0 - financial distress zone
Tailwinds
Confidence
Cinemark Holdings, Inc. (NYSE: CNK) is a major theatrical exhibition company headquartered in Plano, Texas. Since its founding in 1984, the firm has expanded its footprint to operate hundreds of theaters across the United States and Latin America.
The company operates within the Movies & Entertainment sub-industry, a sector that relies heavily on exclusive theatrical windows and high-margin concessions to drive profitability. Cinemark’s business model utilizes a mix of domestic market leadership and international geographic diversification, particularly in Brazil, to mitigate regional economic fluctuations.
To evaluate how these regional operations impact long-term valuation, consider reviewing the detailed metrics on ValueRay. Investors in this space monitor box office cycles and streaming competition as primary drivers of attendance and revenue stability.
- Major studio film slate volume dictates box office revenue potential
- Concession per-capita spending growth offsets fluctuating theatre attendance levels
- Latin American currency volatility impacts consolidated international earnings reports
- Fixed theatre operating costs demand high capacity utilization for profitability
- Direct-to-streaming release windows threaten traditional theatrical exhibition exclusivity models
| Net Income: 170.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.29 > 1.0 |
| NWC/Revenue: -9.37% < 20% (prev -7.95%; Δ -1.42% < -1%) |
| CFO/TA 0.11 > 3% & CFO 494.8m > Net Income 170.1m |
| Net Debt (2.83b) to EBITDA (553.0m): 5.13 < 3 |
| Current Ratio: 0.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.7m) vs 12m ago -3.94% < -2% |
| Gross Margin: 32.57% > 18% (prev 64.38%; Δ -31.81% > 0.5%) |
| Asset Turnover: 71.28% > 50% (prev 64.31%; Δ 6.97% > 0%) |
| Interest Coverage Ratio: 2.26 > 6 (EBIT TTM 349.0m / Interest Expense TTM 154.4m) |
| A: -0.07 (Total Current Assets 486.7m - Total Current Liabilities 788.1m) / Total Assets 4.35b |
| B: -0.02 (Retained Earnings -81.6m / Total Assets 4.35b) |
| C: 0.08 (EBIT TTM 349.0m / Avg Total Assets 4.51b) |
| D: 0.10 (Book Value of Equity 381.1m / Total Liabilities 3.96b) |
| Altman-Z'' = 0.10 = B |
| DSRI: 1.13 (Receivables 146.0m/121.0m, Revenue 3.22b/3.01b) |
| GMI: 1.98 (GM 64.38% / 32.57%) |
| AQI: 1.68 (AQ_t 0.62 / AQ_t-1 0.37) |
| SGI: 1.07 (Revenue 3.22b / 3.01b) |
| TATA: -0.07 (NI 170.1m - CFO 494.8m) / TA 4.35b) |
| Beneish M = -1.59 (Cap -4..+1) = CCC |
As of June 20, 2026, the stock is trading at USD 33.76 with a total of 1,443,484 shares traded.
Over the past week, the price has changed by -0.74%,
over one month by +26.25%,
over three months by +27.20% and
over the past year by +4.74%.
Cinemark Holdings has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy CNK.
- StrongBuy: 3
- Buy: 4
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 35 | 3.7% |
P/E Trailing = 25.4
P/E Forward = 15.1745
P/S = 1.1986
P/B = 10.119
P/EG = 1.7222
Revenue TTM = 3.22b USD
EBIT TTM = 349.0m USD
EBITDA TTM = 553.0m USD
Long Term Debt = 1.87b USD (from longTermDebt, last quarter)
Short Term Debt = 23.1m USD (from shortTermDebt, last quarter)
Debt = 3.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.11b
Net Debt = 2.83b USD (calculated: Debt 3.10b - CCE 261.7m)
Enterprise Value = 6.69b USD (3.86b + Debt 3.10b - CCE 261.7m)
Interest Coverage Ratio = 2.26 (Ebit TTM 349.0m / Interest Expense TTM 154.4m)
EV/FCF = 25.70x (Enterprise Value 6.69b / FCF TTM 260.3m)
FCF Yield = 3.89% (FCF TTM 260.3m / Enterprise Value 6.69b)
FCF Margin = 8.09% (FCF TTM 260.3m / Revenue TTM 3.22b)
Net Margin = 5.29% (Net Income TTM 170.1m / Revenue TTM 3.22b)
Gross Margin = 32.57% ((Revenue TTM 3.22b - Cost of Revenue TTM 2.17b) / Revenue TTM)
Gross Margin QoQ = 20.98% (prev 17.60%)
Tobins Q-Ratio = 1.54 (Enterprise Value 6.69b / Total Assets 4.35b)
Interest Expense / Debt = 4.99% (Interest Expense 154.4m / Debt 3.10b)
Taxrate = 11.70% (23.1m / 197.4m)
NOPAT = 308.2m (EBIT 349.0m * (1 - 11.70%))
Current Ratio = 0.62 (Total Current Assets 486.7m / Total Current Liabilities 788.1m)
Debt / Equity = 8.12 (Debt 3.10b / totalStockholderEquity, last quarter 381.1m)
Debt / EBITDA = 5.13 (Net Debt 2.83b / EBITDA 553.0m)
Debt / FCF = 10.89 (Net Debt 2.83b / FCF TTM 260.3m)
Total Stockholder Equity = 540.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.77% (Net Income 170.1m / Total Assets 4.35b)
RoE = 31.48% (Net Income TTM 170.1m / Total Stockholder Equity 540.4m)
RoCE = 14.49% (EBIT 349.0m / Capital Employed (Equity 540.4m + L.T.Debt 1.87b))
RoIC = 9.01% (NOPAT 308.2m / Invested Capital 3.42b)
WACC = 4.74% (E(3.86b)/V(6.95b) * Re(5.01%) + D(3.10b)/V(6.95b) * Rd(4.99%) * (1-Tc(0.12)))
Discount Rate = 5.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -31.46 | Cagr: -1.70%
[DCF] Terminal Value 77.97% ; FCFF base≈244.3m ; Y1≈280.0m ; Y5≈412.1m
[DCF] Fair Price = 28.83 (EV 6.20b - Net Debt 2.83b = Equity 3.37b / Shares 116.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 68.47 | Revenue CAGR: 3.57% | SUE: 0.60 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.91 | Chg30d=+5.07% | Revisions=+0% | Analysts=10
EPS next Quarter (2026-09-30): EPS=0.82 | Chg30d=-0.37% | Revisions=+9% | Analysts=10
EPS current Year (2026-12-31): EPS=2.16 | Chg30d=+2.42% | Revisions=+33% | GrowthEPS=+107.9% | GrowthRev=+11.2%
EPS next Year (2027-12-31): EPS=2.45 | Chg30d=+1.79% | Revisions=+17% | GrowthEPS=+13.4% | GrowthRev=+3.9%
[Analyst] Revisions Ratio: +33%